CLEMENTON, N.J.--(BUSINESS WIRE)--CRI Worldwide, Inc., a leading provider of clinical research services to the global pharmaceutical industry, has named Kenneth S. King as Chief Executive Officer. Prior to joining CRI Worldwide, King was President of Molecular Medicine at PerkinElmer in Waltham, Ma., where he led the development of the division’s cellular sciences platform through the completion of several acquisitions and the introduction of several new products. King also has held executive positions in Corporate Strategy and Business Development, Sales and Marketing, Research and Development, and Operations Management with PerkinElmer, General Electric and Eaton Corporation. He holds an MBA from the Wharton School of the University of Pennsylvania, an MS in Physics from Case Western Reserve University, and a BS in Engineering Physics from the University of Maine.
